ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,548 | +59.8% | 988 | +112.0% | 0.00% | – |
| Q2 2023 | $16,618 | +367.3% | 466 | +232.9% | 0.00% | – |
| Q1 2023 | $3,556 | -74.4% | 140 | -59.2% | 0.00% | – |
| Q4 2022 | $13,912 | -0.6% | 343 | -17.9% | 0.00% | – |
| Q3 2022 | $14,000 | -26.3% | 418 | -24.4% | 0.00% | – |
| Q2 2022 | $19,000 | +90.0% | 553 | +157.2% | 0.00% | – |
| Q1 2022 | $10,000 | -65.5% | 215 | -50.8% | 0.00% | – |
| Q4 2021 | $29,000 | +52.6% | 437 | +42.8% | 0.00% | – |
| Q3 2021 | $19,000 | +35.7% | 306 | +80.0% | 0.00% | – |
| Q2 2021 | $14,000 | +55.6% | 170 | +30.8% | 0.00% | – |
| Q1 2021 | $9,000 | -10.0% | 130 | -3.7% | 0.00% | – |
| Q4 2020 | $10,000 | +900.0% | 135 | +440.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |